Previous close | 1.4400 |
Open | 1.2500 |
Bid | 1.0900 |
Ask | 1.6000 |
Strike | 65.00 |
Expiry date | 2025-01-17 |
Day's range | 1.2500 - 1.2500 |
Contract range | N/A |
Volume | |
Open interest | 976 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.